102 related articles for article (PubMed ID: 18535109)
1. Prolactin and estrogen up-regulate carboxypeptidase-d to promote nitric oxide production and survival of mcf-7 breast cancer cells.
Abdelmagid SA; Too CK
Endocrinology; 2008 Oct; 149(10):4821-8. PubMed ID: 18535109
[TBL] [Abstract][Full Text] [Related]
2. Testosterone and prolactin increase carboxypeptidase-D and nitric oxide levels to promote survival of prostate cancer cells.
Thomas LN; Morehouse TJ; Too CK
Prostate; 2012 Mar; 72(4):450-60. PubMed ID: 21688280
[TBL] [Abstract][Full Text] [Related]
3. CAT-1-mediated arginine uptake and regulation of nitric oxide synthases for the survival of human breast cancer cell lines.
Abdelmagid SA; Rickard JA; McDonald WJ; Thomas LN; Too CK
J Cell Biochem; 2011 Apr; 112(4):1084-92. PubMed ID: 21308737
[TBL] [Abstract][Full Text] [Related]
4. Carboxypeptidase-D is elevated in prostate cancer and its anti-apoptotic activity is abolished by combined androgen and prolactin receptor targeting.
Thomas LN; Merrimen J; Bell DG; Rendon R; Goffin V; Too CK
Prostate; 2014 May; 74(7):732-42. PubMed ID: 24615730
[TBL] [Abstract][Full Text] [Related]
5. Carboxypeptidase D is up-regulated in raw 264.7 macrophages and stimulates nitric oxide synthesis by cells in arginine-free medium.
Hadkar V; Skidgel RA
Mol Pharmacol; 2001 May; 59(5):1324-32. PubMed ID: 11306718
[TBL] [Abstract][Full Text] [Related]
6. Prolactin/androgen-inducible carboxypeptidase-D increases with nitrotyrosine and Ki67 for breast cancer progression in vivo, and upregulates progression markers VEGF-C and Runx2 in vitro.
Thomas LN; Chedrawe ER; Barnes PJ; Too CKL
Breast Cancer Res Treat; 2017 Jul; 164(1):27-40. PubMed ID: 28364216
[TBL] [Abstract][Full Text] [Related]
7. Fibroblast growth factor-2 stimulates endothelial nitric oxide synthase expression and inhibits apoptosis by a nitric oxide-dependent pathway in Nb2 lymphoma cells.
Murphy PR; Limoges M; Dodd F; Boudreau RT; Too CK
Endocrinology; 2001 Jan; 142(1):81-8. PubMed ID: 11145569
[TBL] [Abstract][Full Text] [Related]
8. Prolactin/Stat5 and androgen R1881 coactivate carboxypeptidase-D gene in breast cancer cells.
Koirala S; Thomas LN; Too CK
Mol Endocrinol; 2014 Mar; 28(3):331-43. PubMed ID: 24433040
[TBL] [Abstract][Full Text] [Related]
9. Prolactin- and testosterone-induced carboxypeptidase-D correlates with increased nitrotyrosines and Ki67 in prostate cancer.
Thomas LN; Merrimen J; Bell DG; Rendon R; Too CK
Prostate; 2015 Nov; 75(15):1726-36. PubMed ID: 26202060
[TBL] [Abstract][Full Text] [Related]
10. L-arginine inhibits apoptosis via a NO-dependent mechanism in Nb2 lymphoma cells.
Dodd F; Limoges M; Boudreau RT; Rowden G; Murphy PR; Too CK
J Cell Biochem; 2000 Apr; 77(4):624-34. PubMed ID: 10771518
[TBL] [Abstract][Full Text] [Related]
11. Carboxypeptidase-mediated enhancement of nitric oxide production in rat lungs and microvascular endothelial cells.
Hadkar V; Sangsree S; Vogel SM; Brovkovych V; Skidgel RA
Am J Physiol Lung Cell Mol Physiol; 2004 Jul; 287(1):L35-45. PubMed ID: 14977629
[TBL] [Abstract][Full Text] [Related]
12. Prolactin and androgen R1881 induce pro-survival carboxypeptidase-D and EDD E3 ligase in triple-negative and HER2+ breast cancer.
MacDonald TM; Thomas LN; Gupta A; Barnes PJ; Too CK
Am J Cancer Res; 2020; 10(5):1321-1343. PubMed ID: 32509382
[TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factor-1 and 17β-estradiol down-regulate prostate apoptosis response-4 expression in MCF-7 breast cancer cells.
Casolari DA; Pereira MC; de Bessa Garcia SA; Nagai MA
Int J Mol Med; 2011 Sep; 28(3):337-42. PubMed ID: 21567071
[TBL] [Abstract][Full Text] [Related]
14. Global profiling of prolactin-modulated transcripts in breast cancer in vivo.
Sato T; Tran TH; Peck AR; Liu C; Ertel A; Lin J; Neilson LM; Rui H
Mol Cancer; 2013 Jun; 12():59. PubMed ID: 23758962
[TBL] [Abstract][Full Text] [Related]
15. Identification and nuclear localization of a novel prolactin and cytokine-responsive carboxypeptidase D.
Too CK; Vickaryous N; Boudreau RT; Sangster SM
Endocrinology; 2001 Mar; 142(3):1357-67. PubMed ID: 11181555
[TBL] [Abstract][Full Text] [Related]
16. Regulation of vitamin D receptor expression via estrogen-induced activation of the ERK 1/2 signaling pathway in colon and breast cancer cells.
Gilad LA; Bresler T; Gnainsky J; Smirnoff P; Schwartz B
J Endocrinol; 2005 Jun; 185(3):577-92. PubMed ID: 15930183
[TBL] [Abstract][Full Text] [Related]
17. Prolactin and estradiol utilize distinct mechanisms to increase serine-118 phosphorylation and decrease levels of estrogen receptor alpha in T47D breast cancer cells.
Chen Y; Huang K; Chen KE; Walker AM
Breast Cancer Res Treat; 2010 Apr; 120(2):369-77. PubMed ID: 19377875
[TBL] [Abstract][Full Text] [Related]
18. Estradiol-induced vascular endothelial growth factor-A expression in breast tumor cells is biphasic and regulated by estrogen receptor-alpha dependent pathway.
Sengupta K; Banerjee S; Saxena N; Banerjee SK
Int J Oncol; 2003 Mar; 22(3):609-14. PubMed ID: 12579315
[TBL] [Abstract][Full Text] [Related]
19. Relative involvement of three 17beta-hydroxysteroid dehydrogenases (types 1, 7 and 12) in the formation of estradiol in various breast cancer cell lines using selective inhibitors.
Laplante Y; Rancourt C; Poirier D
Mol Cell Endocrinol; 2009 Mar; 301(1-2):146-53. PubMed ID: 18812208
[TBL] [Abstract][Full Text] [Related]
20. Regulation of progesterone receptor gene expression in MCF-7 breast cancer cells: a comparison of the effects of cyclic adenosine 3',5'-monophosphate, estradiol, insulin-like growth factor-I, and serum factors.
Cho H; Aronica SM; Katzenellenbogen BS
Endocrinology; 1994 Feb; 134(2):658-64. PubMed ID: 7507831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
